Category: U.S. National Science Foundation
-
Faster, more sensitive lung cancer detection from a blood draw
(Funded by the National Science Foundation, the U.S. Department of Defense, and the National Institutes of Health)
A new way of diagnosing lung cancer with a blood draw is 10 times faster and 14 times more sensitive than earlier methods, according to researchers from the University of Michigan and Rensselaer Polytechnic Institute. The microchip that the researchers developed captures nanoscale particles called exosomes β tiny packages released by cells β from blood plasma to identify signs of lung cancer. Although exosomes from healthy cells move important proteins or DNA and RNA fragments throughout the body, exosomes from cancer cells can help tumors spread by preparing tissues to accept tumor cells before they arrive. Also, cancer cell exosomes can be distinguished from healthy cell exosomes because proteins on the surfaces of cancer cell exosomes are often mutated. -
Researchers create orientation-independent magnetic field-sensing nanotube spin qubits
(Funded by the National Science Foundation)
Purdue University researchers have developed patent-pending one-dimensional boron nitride nanotubes containing spin qubits, or spin defects. These nanotubes are more sensitive in detecting off-axis magnetic fields at high resolution than traditional diamond tips used in scanning probe magnetic-field microscopes. Applications include quantum-sensing technology that measures changes in magnetic fields and collects and analyzes data at the atomic level. -
Nanopillars create tiny openings in the nucleus without damaging cells
(Funded by the U.S. Department of Defense, the National Science Foundation and the National Institutes of Health)
Researchers from the University of California San Diego have created an array of nanopillars that can breach the nucleus of a cell β the compartment that houses our DNA β without damaging the cell’s outer membrane. This new βgateway into the nucleusβ could open new possibilities in gene therapy, where genetic material needs to be delivered directly into the nucleus, as well as drug delivery and other forms of precision medicine. The nucleus is impenetrable by design. Its membrane is a highly fortified barrier that shields our genetic code, letting in only specific molecules through tightly controlled channels. -
Beyond βone pore at a timeβ: New method of generating multiple, tunable nanopores
(Funded by the U.S. Department of Energy and the National Science Foundation)
Nanoporous membranes with holes smaller than one-billionth of a meter have powerful potential for decontaminating polluted water or for osmotic power generators. But these applications have been limited in part by the tedious process of tunneling individual sub-nanometer pores one by one. Now, researchers from the University of Chicago have found a novel path around this long-standing problem. They created a new method of pore generation that builds materials with intentional weak spots and then applies a remote electric field to generate multiple nanoscale pores all at once. -
Siloxane nanoparticles unlock precise organ targeting for mRNA therapy
(Funded by the National Institutes of Health and the National Science Foundation)
Researchers from the University of Pennsylvania, Temple University in Philadelphia, the University of Delaware, and the University of Electronic Science and Technology of China have discovered a novel means of directing lipid nanoparticles to target specific tissues. The engineers demonstrated how subtle adjustments to the chemical structure of an ionizable lipid, a key component of a lipid nanoparticle, allow for tissue-specific delivery to the liver, lungs, and spleen. The researchers’ key insight was to incorporate siloxane composites β a class of silicon- and oxygen-based compounds already used in medical devices, cosmetics and drug delivery β into ionizable lipids.
